A significant discovery in cancer investigation is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This vital tumor inhibitor protein is frequently lost in various forms of tumors, leading https://leftbookmarks.com/story21998198/nanobodies-revive-p53-a-potential-hope-for-cancer-treatment